EWTX — EDGEWISE THERAPEUTICS INC

Ownership history in ALGERT GLOBAL LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in EDGEWISE THERAPEUTICS INC (EWTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2024 Q4)
Avg. % of fund
0.02%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 40,963 +6,240 +18.0% 0.01% $664K $16.22
2025 Q2 REDUCED 34,723 -75,536 -68.5% 0.01% $455K $13.11
2024 Q4 ADDED 110,259 +100,859 +1073.0% 0.07% $2.9M $26.70
2024 Q3 INITIATED 9,400 — — 0.01% $251K $26.69
% of Fund (quarterly)    EWTX price (monthly, adj. close)

Other funds also holding EWTX

As of 2025 Q4 — sorted by position size

Novo Holdings A/S 3Y 7Y 10.31% ORBIMED ADVISORS LLC 3Y 7Y 7.86% Ally Bridge Group (NY) LLC 3Y 6.46% Ally Bridge Group (NY) LLC 3Y 5.04% MPM BioImpact LLC 3Y 4.7% Paradigm Biocapital Advisors LP 3Y 4.14% BRAIDWELL LP 3Y 4.14% Cormorant Asset Management, LP 3Y 7Y 3.77% Siren, L.L.C. 3.35% First Light Asset Management, LLC 3Y 7Y 2.99%
← Back to ALGERT GLOBAL LLC Holdings